Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Selonsertib

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AASLD: Gilead wants to move the needle for fatty liver therapies
    AASLD: Gilead wants to move the needle for fatty liver therapies

    11 Nov 2019

    // A. A Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/aasld-gilead-wants-to-move-needle-for-fatty-liver-therapies

    A. A Idrus FIERCE BIOTECH
    11 Nov 2019
    Share Share
    Gilead experimental NASH drug fails another study
    Gilead experimental NASH drug fails another study

    26 Apr 2019

    // Manas Mishra REUTERS

    https://www.reuters.com/article/us-gilead-sciences-nash/gilead-experimental-nash-drug-fails-another-study-idUSKCN1S11IM?feedType=RSS&feedName=healthNews

    Manas Mishra REUTERS
    26 Apr 2019
    Share Share
    Gilead teams up with Insitro for experimental NASH treatments
    Gilead teams up with Insitro for experimental NASH treatments

    17 Apr 2019

    // Saumya S. Joseph REUTERS

    https://www.reuters.com/article/us-gilead-sciences-insitro-nash/gilead-teams-up-with-insitro-for-experimental-nash-treatments-idUSKCN1RS11J?feedType=RSS&feedName=healthNews

    Saumya S. Joseph REUTERS
    17 Apr 2019
    Share Share
    Pipeline revamp. Forward thrust. What does a decade of deals at Gilead
    Pipeline revamp. Forward thrust. What does a decade of deals at Gilead

    04 Mar 2019

    // John Carroll ENDPTS

    https://endpts.com/team-building-pipeline-revamp-forward-thrust-what-does-a-decade-of-deals-at-gilead-tell-us-about-daniel-odays-first-moves/

    John Carroll ENDPTS
    04 Mar 2019
    Share Share
    Gilead misses key goal in NASH liver disease trial, shares sink
    Gilead misses key goal in NASH liver disease trial, shares sink

    12 Feb 2019

    // Julie Steenhuysen REUTERS

    https://www.reuters.com/article/us-gileadsciences-nash/gilead-misses-key-goal-in-nash-liver-disease-trial-shares-sink-idUSKCN1Q02HU

    Julie Steenhuysen REUTERS
    12 Feb 2019
    Share Share
    Gilead Announces Topline Data From Ph 3 Study of Selonsertib in NASH
    Gilead Announces Topline Data From Ph 3 Study of Selonsertib in NASH

    12 Feb 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190211005738/en

    BUSINESSWIRE
    12 Feb 2019
    Share Share